Advancing the science of survival from severe infection and sepsis in resource limited areas. One Team!
Severe infection and sepsis take more than 11 million lives each year. The ATLAS team propels host-response science forward to understand the underlying biology of sepsis, identify risk earlier, guide treatment more precisely, and give patients a better chance of survival.
Together, we can advance host-response diagnostics and therapies with a shared purpose: enriching and saving precious lives.
Partner with ATLAS Explore ATLAS
Formerly ACESO | 5 Continents, | Nearly 6,000 | U.S. + International |
|---|---|---|---|
Discovery, transitional biology, global engagement, and clinical evaluation in one organization. | Clinical research network with pre-approved protocols. | Patients with severe infection profiled in multi-omic host-response datasets. | Civilian and military study sites under FDA-compliant protocols. |
Translational biology expertise. Global health reach. A shared clinical purpose.
Host-response expertise. Global clinical reach. A shared scientific purpose. | Our Mission | |
|---|---|---|
Transforming care for the most difficult clinical cases requires more than a promising mechanism or a capable trial network. It requires a connection between a dedicated team, the people we serve, and a vast and powerful understanding of the underlying biology to which therapeutic solutions can be directed. ATLAS converges those perspectives under one program. Our researchers, global partners, and clinical evaluation teams collaborate to develop meaningful questions, interpret patient variability, and design impactful studies that will have the greatest clinical impact for the patient. We work alongside academic, government, international and biotech partners to connect transformational biology and host-response science with clinical evaluation. Our integrated research capabilities, curated patient data, world-class computational analytics, and global clinical network help promising solutions that will make a difference. For partners, that means access to a diverse and integrated scientific team, not simply a study site or a dataset. For our mission, it means research shaped by our patient populations at their point of need. | Deliver sustainable solutions that mitigate the maladaptive host response to severe infection and sepsis, and transform the global standard of care. | |
Our Vision | ||
| A future in which precise, data-driven decisions guide severe infection care wherever patients are treated. We aim to connect biological insight, actionable diagnostics, and effective treatment strategies across civilian, military, and resource-limited settings. |